161 related articles for article (PubMed ID: 24056200)
21. Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature.
Plante M; Touhami O; Trinh XB; Renaud MC; Sebastianelli A; Grondin K; Gregoire J
Gynecol Oncol; 2015 Jun; 137(3):443-7. PubMed ID: 25771495
[TBL] [Abstract][Full Text] [Related]
22. The use of indocyanine green to detect sentinel nodes in breast cancer: a prospective study.
Samorani D; Fogacci T; Panzini I; Frisoni G; Accardi FG; Ricci M; Fabbri E; Nicoletti S; Flenghi L; Tamburini E; Tassinari D; Gianni L
Eur J Surg Oncol; 2015 Jan; 41(1):64-70. PubMed ID: 25468752
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent Versus Radioguided Lymph Node Mapping in Bladder Cancer.
Polom W; Markuszewski M; Cytawa W; Czapiewski P; Lass P; Matuszewski M
Clin Genitourin Cancer; 2017 Jun; 15(3):e405-e409. PubMed ID: 28007368
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparison of near-infrared fluorescence lymphatic tracers for sentinel lymph node mapping of cervical cancer.
Schaafsma BE; van der Vorst JR; Gaarenstroom KN; Peters AA; Verbeek FP; de Kroon CD; Trimbos JB; van Poelgeest MI; Frangioni JV; van de Velde CJ; Vahrmeijer AL
Gynecol Oncol; 2012 Oct; 127(1):126-30. PubMed ID: 22796548
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma.
Namikawa K; Yamazaki N
Eur J Dermatol; 2011; 21(2):184-90. PubMed ID: 21498148
[TBL] [Abstract][Full Text] [Related]
26. Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study.
Rossi EC; Ivanova A; Boggess JF
Gynecol Oncol; 2012 Jan; 124(1):78-82. PubMed ID: 21996262
[TBL] [Abstract][Full Text] [Related]
27. Skin melanoma sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green and indocyanine green with human serum albumin.
Polom K; Murawa D; Rho YS; Spychala A; Murawa P
Br J Dermatol; 2012 Mar; 166(3):682-3. PubMed ID: 21923754
[No Abstract] [Full Text] [Related]
28. Indocyanine green fluorescence-guided sentinel lymph node biopsy in dermato-oncology.
Stoffels I; von der Stück H; Boy C; Pöppel T; Körber N; Weindorf M; Dissemond J; Schadendorf D; Klode J
J Dtsch Dermatol Ges; 2012 Jan; 10(1):51-7. PubMed ID: 22103392
[TBL] [Abstract][Full Text] [Related]
29. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomised comparison of lymphatic tracers.
Schaafsma BE; Verbeek FP; Peters AA; van der Vorst JR; de Kroon CD; van Poelgeest MI; Trimbos JB; van de Velde CJ; Frangioni JV; Vahrmeijer AL; Gaarenstroom KN
BJOG; 2013 May; 120(6):758-64. PubMed ID: 23418877
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in cutaneous head and neck/lip mucosa melanomas.
Hayashi T; Furukawa H; Oyama A; Funayama E; Saito A; Yamao T; Yamamoto Y
Head Neck; 2012 May; 34(5):758-61. PubMed ID: 21246639
[TBL] [Abstract][Full Text] [Related]
31. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
[TBL] [Abstract][Full Text] [Related]
32. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
33. Systematic review and meta-analysis concerning near-infrared imaging with fluorescent agents to identify the sentinel lymph node in oncology patients.
Jeremiasse B; van den Bosch CH; Wijnen MWHA; Terwisscha van Scheltinga CEJ; Fiocco MF; van der Steeg AFW
Eur J Surg Oncol; 2020 Nov; 46(11):2011-2022. PubMed ID: 32826112
[TBL] [Abstract][Full Text] [Related]
34. An experimental study to evaluate the Fluobeam 800 imaging system for fluorescence-guided lymphatic imaging and sentinel node biopsy.
Hirche C; Engel H; Kolios L; Cognie J; Hünerbein M; Lehnhardt M; Kremer T
Surg Innov; 2013 Oct; 20(5):516-23. PubMed ID: 23275469
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
Brar H; Hogen L; Covens A
Cancer; 2017 May; 123(10):1751-1759. PubMed ID: 28117888
[TBL] [Abstract][Full Text] [Related]
36. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: comparison with infrared imaging.
Miyashiro I; Miyoshi N; Hiratsuka M; Kishi K; Yamada T; Ohue M; Ohigashi H; Yano M; Ishikawa O; Imaoka S
Ann Surg Oncol; 2008 Jun; 15(6):1640-3. PubMed ID: 18379850
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic sentinel lymph node biopsy using indocyanine green-neomannosyl human serum albumin.
Park YM; Quan YH; Kwon KH; Cho JG; Woo JS; Kim BM; Lee YS; Jeong JM; Kim HK; Song JJ
Laryngoscope; 2018 Apr; 128(4):E135-E140. PubMed ID: 29214646
[TBL] [Abstract][Full Text] [Related]
38. Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma.
de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
Eur J Surg Oncol; 2005 Sep; 31(7):778-83. PubMed ID: 15993029
[TBL] [Abstract][Full Text] [Related]
39. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
[TBL] [Abstract][Full Text] [Related]
40. Improvement of the sentinel lymph node detection rate of cervical sentinel lymph node biopsy using real-time fluorescence navigation with indocyanine green in head and neck skin cancer.
Nakamura Y; Fujisawa Y; Nakamura Y; Maruyama H; Furuta J; Kawachi Y; Otsuka F
J Dermatol; 2013 Jun; 40(6):453-7. PubMed ID: 23621899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]